For How Long Should the Treatment with Vitamin K Antagonists Be Maintained?

Publisher： Karger

E-ISSN： 1424-8840|29|1|89-90

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.29, Iss.1, 2004-11, pp. : 89-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with Vitamin K Antagonists: Frequency of Indications and Appropriateness of Continuation

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 111-114

Karger

Access to resources Recommend Favorite

Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 9, 2015-09 ,pp. : 1590-1596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 1, 2015-07 ,pp. : 54-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Malaria-treatment policies: when and how should they be changed?

By Fevre E. M.   Barnish G.  

Annals of Tropical Medicine and Parasitology, Vol. 93, Iss. 6, 1999-09 ,pp. : 549-560

Routledge Ltd

Access to resources Recommend Favorite